Abstract:Background Breast cancer is one of the most common cancers and the leading cause of death from cancer among women worldwide. The genetic predisposition to breast cancer may be associated with a mutation in particular genes such as gene BRCA1/2. Patients who carry a germline pathogenic mutation in BRCA1/2 genes have a significantly increased risk of developing breast cancer and might benefit from targeted therapy. However, genetic testing is time consuming and costly. This study aims to predict the risk of gBRCA mutation by using the whole-slide pathology features of breast cancer H&E stains and the patients’ gBRCA mutation status. Methods In this study, we trained a deep convolutional neural network (CNN) of ResNet on whole-slide images (WSIs) to predict the gBRCA mutation in breast cancer. Since the dimensions are too large for slide-based training, we divided WSI into smaller tiles with the original resolution. The tile-based classification was then combined by adding the positive classification result to generate the combined slide-based accuracy. Models were trained based on the annotated tumor location and gBRCA mutation status labeled by a designated breast cancer pathologist. Four models were trained on tiles cropped at 5×, 10×, 20×, and 40× magnification, assuming that low magnification and high magnification may provide different levels of information for classification. Results A trained model was validated through an external dataset that contains 17 mutants and 47 wilds. In the external validation dataset, AUCs (95% CI) of DL models that used 40×, 20×, 10×, and 5× magnification tiles among all cases were 0.766 (0.763–0.769), 0.763 (0.758–0.769), 0.750 (0.738–0.761), and 0.551 (0.526–0.575), respectively, while the corresponding magnification slides among all cases were 0.774 (0.642–0.905), 0.804 (0.676–0.931), 0.828 (0.691–0.966), and 0.635 (0.471–0.798), respectively. The study also identified the influence of histological grade to the accuracy of the prediction. Conclusion In this paper, the combination of pathology and molecular omics was used to establish the gBRCA mutation risk prediction model, revealing the correlation between the whole-slide histopathological images and gRCA mutation risk. The results indicated that the prediction accuracy is likely to improve as the training data expand. The findings demonstrated that deep CNNs could be used to assist pathologists in the detection of gene mutation in breast cancer.

Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning

ICSDA: a multi-modal deep learning model to predict breast cancer recurrence and metastasis risk by integrating pathological, clinical and gene expression data

Deep Learning-Based Radiomics Models for Early Recurrence Prediction of Hepatocellular Carcinoma with Multi-phase CT Images and Clinical Data.

Cervical Cancer Metastasis and Recurrence Risk Prediction Based on Deep Convolutional Neural Network

Predicting the risk of early-stage breast cancer recurrence using H\&E-stained tissue images

[Intelligent Prediction of HER2 Status Based on Breast Histopathology].

Prediction of Breast Cancer Recurrence Using a Deep Convolutional Neural Network Without Region-of-Interest Labeling

Improving HER2-Positive Breast Cancer Targeted Therapy Prediction Using Multimsnet: A Multi-Scale Pathological Image-Based Approach

Predicting the prognosis of HER2-positive breast cancer patients by fusing pathological whole slide images and clinical features using multiple instance learning

Prediction of HER2 Status Based on Deep Learning in H&E-Stained Histopathology Images of Bladder Cancer

Prediction of BRCA Gene Mutation in Breast Cancer Based on Deep Learning and Histopathology Images

Immunohistochemical HER2 Recognition and Analysis of Breast Cancer Based on Deep Learning

Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence

Predicting HER2 Status in Breast Cancer on Ultrasound Images Using Deep Learning Method

Predicting Lymph Node Metastasis from Primary Cervical Squamous Cell Carcinoma Based on Deep Learning in Histopathologic Images.

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning

HER2 and FISH Status Prediction in Breast Biopsy H&E-Stained Images Using Deep Learning

Two-step Segmentation of Hematoxylin-Eosin Stained Histopathological Images for Prognosis of Breast Cancer

Computational Pathology for Accurate Prediction of Breast Cancer Recurrence: Development and Validation of a Deep Learning-based Tool

Predicting gastric cancer tumor mutational burden from histopathological images using multimodal deep learning

Multi-stain modelling of histopathology slides for breast cancer prognosis prediction